Deep Dive: Deep Dive Into Pre-Exposure Prophylaxis Monoclonal Antibodies

Monoclonal antibodies have become a beacon of hope for patients at high risk of COVID-19 who may not have a full response to the vaccines, or for whom vaccination isn’t an option. In an interview with Pharmacy Times, Alfred L’Altrelli, senior director of pharmacy at UPMC Presbyterian-Shadyside, discussed how pharmacists are ensuring patient access to these important treatments.